Theravance Biopharma Inc ( TBPH) - Key Metrics
TBPH Revenue per Share metrics
| Date | Revenue per Share | Net Income per Share | Operating Cash Flow | Free Cash Flow per Share |
|---|---|---|---|---|
| 2026Q2 | $0.40 | -$0.11 | -$0.17 | -$0.17 |
| 2026Q1 | $0.35 | -$0.10 | $1.43 | $1.43 |
| 2025Q4 | $0.90 | $1.20 | -$0.12 | -$0.12 |
| 2025Q3 | $0.40 | $0.07 | -$0.13 | -$0.13 |
| 2025Q2 | $0.52 | $1.09 | $4.15 | $4.15 |
TBPH Payout ratio and Price per Earnings ratio
| Date | Payout ratio | PE ratio |
|---|---|---|
| 2026Q2 | 0% | -38.64 |
| 2026Q1 | 0% | -42.18 |
| 2025Q4 | 0% | 3.90 |
| 2025Q3 | 0% | 52.14 |
| 2025Q2 | 0% | 2.53 |
TBPH
Price: $17.03
52 week price:
Payout Ratio Range:
Earnings Per Share: 1.04 USD
P/E Ratio: 16.32
Exchange: NGM
Sector: Healthcare
Industry: Biotechnology
Country: Cayman Islands
Volume: 260600
Ebitda: -62.9 millionMarket Capitalization: 882.6 million